Few eligible young women choose to take HPV vaccine to prevent cervical cancer, study shows

Nov 09, 2010

In a study of more than 9,600 adolescent and young adult women in the Baltimore area, researchers at the University of Maryland School of Medicine have found that fewer than 30 percent of those eligible to receive the human papillomavirus (HPV) vaccine to prevent cervical cancer actually chose to get it. And only about a third of those who began receiving the vaccine completed the three doses recommended for maximum protection.

The research, which was led by J. Kathleen Tracy, Ph.D., an assistant professor of epidemiology, will be presented on Nov. 9, 2010, at a cancer prevention research conference in Philadelphia sponsored by the American Association for Cancer Research.

"Despite strong evidence that the is highly effective, our study showed that relatively few women choose to take it, and the majority of them don't complete the recommended series of doses," Dr. Tracy says. "This means that large numbers of these young women are unprotected or under-protected from strains of HPV that lead to ."

HPV is the most common sexually transmitted disease among in the United States, with 29.5 percent of sexually active 14- to 19-year-olds infected at any given time. Persistent infection with certain strains of HPV has been shown to cause cervical cancer. Vaccines that target the most common strains of HPV have been licensed in the United States since 2006. Doctors recommend the vaccine for girls and young women from ages 12 to 26 years old, although girls as young as 9 years old can take it.

E. Albert Reece, M.D., Ph.D., M.B.A., vice president of medical affairs at the University of Maryland and dean of the University of Maryland School of Medicine, says, "HPV vaccines have the potential to greatly reduce and possibly even eliminate cervical cancer in those most at risk of developing it. However, these vaccines are only effective if young women choose to be vaccinated and receive the recommended dosage. Dr. Tracy's research raises significant public health concerns about whether this at-risk population is being adequately protected." Dr. Reece, a gynecologist, also notes that vaccination against HPV doesn't eliminate the need for annual cervical cancer screening.

The study was based on clinical data from the University of Maryland Medical Center's outpatient gynecology clinics, where 9,658 adolescent and young adult women, ages 9 to 26, who were potentially eligible for the vaccine were seen from August 2006 until August 2010. Of these, 2,641 young women, or 27.3 percent, started the vaccination process – 39.1 percent completed one dose, 30.1 percent completed two doses and 30.78 percent completed all three doses. Two-thirds of those who began taking the vaccine were African-American.

Young women, ages 18 to 26, were the least likely to complete more than a single dose of the vaccine. African-American women were less likely than young white women to complete all three doses, according to the research.

"We don't know why the young women in our study opted not to take the vaccine or failed to complete the three-dose regimen," says Dr. Tracy, who is a health psychologist. "But our research very clearly points out the need to develop strategies to encourage eligible women to take the vaccine as directed for maximum protection. Parents may have to take a more active role in making sure their daughters receive all the necessary doses."

Dr. Tracy notes that she and her University of Maryland colleagues are planning to conduct a small clinical trial to determine if sending patients text-message reminders might increase the number of people who complete the vaccination process. "We need to develop evidence-based interventions to foster increased participation in vaccine programs and eliminate barriers for young women, in particular, minority women," Dr. Tracy says.

Explore further: Patient-centered medical homes reduce costs

Provided by University of Maryland Medical Center

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

One in four California adolescent girls has had HPV vaccine

Feb 17, 2009

Less than two years after the HPV vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, ...

Study: HPV vaccine hurts less than expected

Oct 21, 2009

(PhysOrg.com) -- Injections of the human papillomavirus (HPV) vaccine appear to be no more painful than other shots that prevent disease, according to a new study by researchers at the University of North Carolina at Chapel ...

Recommended for you

Patient-centered medical homes reduce costs

17 hours ago

The patient-centered medical home (PCMH), introduced in 2007, is a model of health care that emphasizes personal relationships, team delivery of care, coordination across specialties and care settings, quality ...

New mums still excessively sleepy after four months

18 hours ago

(Medical Xpress)—New mums are being urged to be cautious about returning to work too quickly, after a QUT study found one in two were still excessively sleepy four months after giving birth.

It's time to address the health of men around the world

18 hours ago

All over the world, men die younger than women and do worse on a host of health indicators, yet policy makers rarely focus on this "men's health gap" or adopt programs aimed at addressing it, according to an international ...

User comments : 0